Mast cells: “central regulatory hub” of neuro-endocrine-immune dysregulation in vitiligo - Report - MDSpire

Mast cells: “central regulatory hub” of neuro-endocrine-immune dysregulation in vitiligo

  • By

  • Chen Zhang

  • Zhanhong Cao

  • Yuxin Bai

  • Xuanxuan Zhu

  • Yue Shen

  • Zhenhua Wang

  • Jincai Li

  • Wenjian Wang

  • Meng Zhang

  • June 26, 2026

  • 0 min

Share

Clinical Report: Mast Cells as Key Regulators in Vitiligo

Overview

Mast cells (MCs) play a role in the interplay between the neuroendocrine and immune systems in vitiligo. Their activation leads to the release of various mediators that influence melanocyte function and disease progression.

Background

Vitiligo is a skin disorder characterized by the loss of melanocytes, leading to depigmentation. The etiology involves genetic, oxidative, autoimmune, and neurogenic factors, but current models do not fully explain the disease mechanism. Understanding the role of mast cells in this context could provide insights.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Mast cells are mediators in the neuroendocrine and immune systems.
  • Activation of mast cells leads to the secretion of various regulatory mediators affecting melanocyte function.
  • Current therapeutic agents targeting mast cells include ketotifen and imatinib.
  • Mast cells exhibit interactions with neural and endocrine systems.

Clinical Implications

Understanding the role of mast cells may enhance treatment approaches for patients.

Conclusion

Mast cells are integral to the pathophysiology of vitiligo.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Regulatory T cells in vitiligo: a review of functional disequilibrium between peripheral blood and lesional tissue
  2. Frontiers in Immunology, 2026 -- NK cell hyperactivation drives macrophage repolarization and limits M2 bias in pemphigus vulgaris
  3. Frontiers in Immunology, 2026 -- Mast cells shape early pulmonary inflammation and regulate dendritic cell abundance and localization after chemical induced lung injury
  4. Journal of Neuro-Oncology -- Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema
  5. JAMA Dermatology -- Definition of Severity and Relapse for Vitiligo
  6. Nature Reviews Disease Primers -- Vitiligo
  7. Definition of Severity and Relapse for Vitiligo
  8. https://academic.oup.com/bjd/article/194/3/591/8382205
  9. Vitiligo | Nature Reviews Disease Primers

Original Source(s)

Mast cells: “central regulatory hub” of neuro-endocrine-immune dysregulation in vitiligo

  • by Chen Zhang, Zhanhong Cao, Yuxin Bai, Xuanxuan Zhu, Yue Shen, Zhenhua Wang, Jincai Li, Wenjian Wang, Meng Zhang

  • June 26, 2026

Related Content

The Bacterial Landscape of Facial Skin: From Homeostasis to Skin Conditions

Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian Practice

New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification